These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 9486608)

  • 1. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.
    Leung TW; Lau WY; Ho SK; Ward SC; Chow JH; Chan MS; Metreweli C; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):919-24. PubMed ID: 7591903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.
    Ho S; Lau WY; Leung TW; Chan M; Johnson PJ; Li AK
    Eur J Nucl Med; 1997 Mar; 24(3):293-8. PubMed ID: 9143467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?
    Lau WY; Ho S; Leung WT; Chan M; Lee WY; Johnson PJ
    Hepatogastroenterology; 2001; 48(38):338-40. PubMed ID: 11379304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
    Salem R; Lewandowski R; Roberts C; Goin J; Thurston K; Abouljoud M; Courtney A
    J Vasc Interv Radiol; 2004 Apr; 15(4):335-45. PubMed ID: 15064336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.
    Lau WY; Leung WT; Ho S; Leung NW; Chan M; Lin J; Metreweli C; Johnson P; Li AK
    Br J Cancer; 1994 Nov; 70(5):994-9. PubMed ID: 7947110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
    Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
    Pöpperl G; Helmberger T; Münzing W; Schmid R; Jacobs TF; Tatsch K
    Cancer Biother Radiopharm; 2005 Apr; 20(2):200-8. PubMed ID: 15869456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a case report.
    Rivera L; Giap H; Miller W; Fisher J; Hillebrand DJ; Marsh C; Schaffer RL
    World J Gastroenterol; 2006 Sep; 12(35):5729-32. PubMed ID: 17007031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.
    Shepherd FA; Rotstein LE; Houle S; Yip TC; Paul K; Sniderman KW
    Cancer; 1992 Nov; 70(9):2250-4. PubMed ID: 1327493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
    Garin E; Tselikas L; Guiu B; Chalaye J; Edeline J; de Baere T; Assenat E; Tacher V; Robert C; Terroir-Cassou-Mounat M; Mariano-Goulart D; Amaddeo G; Palard X; Hollebecque A; Kafrouni M; Regnault H; Boudjema K; Grimaldi S; Fourcade M; Kobeiter H; Vibert E; Le Sourd S; Piron L; Sommacale D; Laffont S; Campillo-Gimenez B; Rolland Y;
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):17-29. PubMed ID: 33166497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
    Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
    Riaz A; Gates VL; Atassi B; Lewandowski RJ; Mulcahy MF; Ryu RK; Sato KT; Baker T; Kulik L; Gupta R; Abecassis M; Benson AB; Omary R; Millender L; Kennedy A; Salem R
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):163-71. PubMed ID: 20421150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma].
    Liang L; Huang J; Yin X; Lu M; Rao G; Ren Z; Li D; Kuang M
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):743-6. PubMed ID: 11829942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.